Literature DB >> 22155419

Formation of P450 · P450 complexes and their effect on P450 function.

James R Reed1, Wayne L Backes.   

Abstract

Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b(5). Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450 · P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450 · P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155419      PMCID: PMC3272114          DOI: 10.1016/j.pharmthera.2011.11.009

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  76 in total

1.  Immobilized cytochrome P-450LM2. Dissociation and reassociation of oligomers.

Authors:  K N Myasoedova; P Berndt
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

2.  Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2-dependent activities.

Authors:  K M Causey; C S Eyer; W L Backes
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

3.  Membrane topology of microsomal cytochrome P-450: saturation transfer EPR and freeze-fracture electron microscopy studies.

Authors:  D Schwarz; J Pirrwitz; H W Meyer; M J Coon; K Ruckpaul
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

4.  Kinetic studies on reduction of cytochromes P-450 and b5 by dithionite.

Authors:  D R Davydov; A V Karyakin; B Binas; B I Kurganov; A I Archakov
Journal:  Eur J Biochem       Date:  1985-07-01

5.  Effect of a zwitterionic detergent on the state of aggregation and catalytic activity of cytochrome P-450LM2 and NADPH-cytochrome P-450 reductase.

Authors:  S L Wagner; W L Dean; R D Gray
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

6.  Incorporation of cytochrome b5 into rat liver microsomal membranes. Impairment of cytochrome P-450-dependent mixed function oxidase activity.

Authors:  G G Gibson; S E Clarke
Journal:  Biochem Pharmacol       Date:  1986-12-15       Impact factor: 5.858

7.  Quaternary structure of the liver microsomal cytochrome P-450.

Authors:  V L Tsuprun; K N Myasoedova; P Berndt; O N Sograf; E V Orlova; A I Archakov; V P Skulachev
Journal:  FEBS Lett       Date:  1986-09-01       Impact factor: 4.124

8.  Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450.

Authors:  A J Sonderfan; M P Arlotto; D R Dutton; S K McMillen; A Parkinson
Journal:  Arch Biochem Biophys       Date:  1987-05-15       Impact factor: 4.013

9.  Cytochrome P-450 LM2 reduction. Substrate effects on the rate of reductase-LM2 association.

Authors:  W L Backes; C S Eyer
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

10.  Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component-purified cytochrome P-450 isozymes.

Authors:  L S Kaminsky; F P Guengerich; G A Dannan; S D Aust
Journal:  Arch Biochem Biophys       Date:  1983-08       Impact factor: 4.013

View more
  42 in total

1.  Effect of homomeric P450-P450 complexes on P450 function.

Authors:  James R Reed; J Patrick Connick; Dongmei Cheng; George F Cawley; Wayne L Backes
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

2.  Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; James R Halpert
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

Review 3.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

4.  Use of high-throughput enzyme-based assay with xenobiotic metabolic capability to evaluate the inhibition of acetylcholinesterase activity by organophosphorous pesticides.

Authors:  Shuaizhang Li; Jinghua Zhao; Ruili Huang; Michael F Santillo; Keith A Houck; Menghang Xia
Journal:  Toxicol In Vitro       Date:  2019-01-06       Impact factor: 3.500

Review 5.  Cell biology of the endoplasmic reticulum and the Golgi apparatus through proteomics.

Authors:  Jeffrey Smirle; Catherine E Au; Michael Jain; Kurt Dejgaard; Tommy Nilsson; John Bergeron
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

6.  Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of α-naphthoflavone.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; Irina Kufareva; James R Halpert
Journal:  Biochem J       Date:  2013-07-15       Impact factor: 3.857

7.  Altered CYP2C9 activity following modulation of CYP3A4 levels in human hepatocytes: an example of protein-protein interactions.

Authors:  Diane Ramsden; Donald J Tweedie; Tom S Chan; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

8.  Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.

Authors:  Ilia G Denisov; Javier L Baylon; Yelena V Grinkova; Emad Tajkhorshid; Stephen G Sligar
Journal:  Biochemistry       Date:  2017-12-14       Impact factor: 3.162

9.  Combinatorial biosynthesis of sapogenins and saponins in Saccharomyces cerevisiae using a C-16α hydroxylase from Bupleurum falcatum.

Authors:  Tessa Moses; Jacob Pollier; Lorena Almagro; Dieter Buyst; Marc Van Montagu; María A Pedreño; José C Martins; Johan M Thevelein; Alain Goossens
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

10.  Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Biochemistry       Date:  2013-05-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.